| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells.
|
Proc Natl Acad Sci U S A
|
2005
|
1.19
|
|
2
|
Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T10.
|
FEBS Lett
|
2002
|
1.12
|
|
3
|
Molecular cloning and characterization of a novel UDP-Gal:GalNAc(alpha) peptide beta 1,3-galactosyltransferase (C1Gal-T2), an enzyme synthesizing a core 1 structure of O-glycan.
|
J Biol Chem
|
2002
|
1.08
|
|
4
|
A novel I-branching beta-1,6-N-acetylglucosaminyltransferase involved in human blood group I antigen expression.
|
Blood
|
2002
|
1.04
|
|
5
|
Characterization of a heparan sulfate 3-O-sulfotransferase-5, an enzyme synthesizing a tetrasulfated disaccharide.
|
J Biol Chem
|
2003
|
1.00
|
|
6
|
Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T15.
|
FEBS Lett
|
2004
|
0.99
|
|
7
|
Cloning and characterization of a novel UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14.
|
Biochem Biophys Res Commun
|
2003
|
0.99
|
|
8
|
LARGE2 facilitates the maturation of alpha-dystroglycan more effectively than LARGE.
|
Biochem Biophys Res Commun
|
2005
|
0.97
|
|
9
|
Changes in physical function after palliative surgery for metastatic spinal tumor: association of the revised Tokuhashi score with neurologic recovery.
|
Spine (Phila Pa 1976)
|
2008
|
0.94
|
|
10
|
Multicenter phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma.
|
J Orthop Sci
|
2010
|
0.93
|
|
11
|
A novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer.
|
FEBS Lett
|
2005
|
0.92
|
|
12
|
RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma.
|
Epigenetics
|
2013
|
0.82
|
|
13
|
Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
|
Ann Surg Oncol
|
2013
|
0.80
|
|
14
|
Prognostic Value of Relevant Clinicopathologic Variables in Epithelioid Sarcoma: A Multi-Institutional Retrospective Study of 44 Patients.
|
Ann Surg Oncol
|
2015
|
0.75
|